NasdaqGM - Delayed Quote USD

biote Corp. (BTMD)

5.52 -0.06 (-1.08%)
At close: April 26 at 4:00 PM EDT
5.52 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Key Events
Loading Chart for BTMD
DELL
  • Previous Close 5.58
  • Open 5.51
  • Bid 5.47 x 100
  • Ask 5.55 x 100
  • Day's Range 5.40 - 5.73
  • 52 Week Range 3.65 - 8.22
  • Volume 68,915
  • Avg. Volume 114,528
  • Market Cap (intraday) 414.187M
  • Beta (5Y Monthly) 0.87
  • PE Ratio (TTM) 42.46
  • EPS (TTM) 0.13
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.65

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

biote.com

194

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BTMD

Performance Overview: BTMD

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BTMD
11.74%
S&P 500
6.92%

1-Year Return

BTMD
8.00%
S&P 500
25.26%

3-Year Return

BTMD
--
S&P 500
21.92%

5-Year Return

BTMD
--
S&P 500
21.92%

Compare To: BTMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BTMD

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    199.91M

  • Enterprise Value

    225.77M

  • Trailing P/E

    42.46

  • Forward P/E

    9.68

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.77

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.22

  • Enterprise Value/EBITDA

    24.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.79%

  • Return on Assets (ttm)

    18.14%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    185.36M

  • Net Income Avi to Common (ttm)

    3.32M

  • Diluted EPS (ttm)

    0.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    89M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    22.59M

Research Analysis: BTMD

Analyst Price Targets

7.00
8.65 Average
5.52 Current
10.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: BTMD

Fair Value

5.52 Current
 

Dividend Score

0 Low
BTMD
Sector Avg.
100 High
 

Hiring Score

0 Low
BTMD
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
BTMD
Sector Avg.
100 High
 

People Also Watch